Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An update on the central nervous system manifestations of neurofibromatosis type 1
J. Stephen Nix, Jaishri O. Blakeley, Fausto J. Rodríguez
Acta Neuropathologica (2019) Vol. 139, Iss. 4, pp. 625-641
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis
Ryota Tamura
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5850-5850
Open Access | Times Cited: 161
EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection
David Capper, Guido Reifenberger, Pim J. French, et al.
Neuro-Oncology (2023) Vol. 25, Iss. 5, pp. 813-826
Open Access | Times Cited: 65
ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1
Charlotte Carton, D. Gareth Evans, Ignacio Blanco, et al.
EClinicalMedicine (2023) Vol. 56, pp. 101818-101818
Open Access | Times Cited: 53
Current Approaches and Future Directions for the Treatment of mTORopathies
Vasiliki Karalis, Helen S. Bateup
Developmental Neuroscience (2021) Vol. 43, Iss. 3-4, pp. 143-158
Open Access | Times Cited: 58
Neurofibromatosis Type 1: Pediatric Aspects and Review of Genotype–Phenotype Correlations
Cristina Peduto, Mariateresa Zanobio, Vincenzo Nigro, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1217-1217
Open Access | Times Cited: 23
Current status and potential role of circular RNAs in neurological disorders
Shanshan Lu, Xue Yang, Chudong Wang, et al.
Journal of Neurochemistry (2019) Vol. 150, Iss. 3, pp. 237-248
Open Access | Times Cited: 53
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1
Calixto‐Hope G. Lucas, Emily A. Sloan, Rohit Gupta, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 4, pp. 747-765
Open Access | Times Cited: 27
Essential Management of Pediatric Brain Tumors
Katharina Lutz, Stephanie T. Jünger, Martina Messing‐Jünger
Children (2022) Vol. 9, Iss. 4, pp. 498-498
Open Access | Times Cited: 26
Focal areas of signal intensity in Neurofibromatosis - type 1
Alcinei Ribeiro Campos, Milad Ardakani
Radiopaedia.org (2025)
Closed Access
The nature and pathological impact of the c.1748A > G variant of the neurofibromin 1 gene
Ji‐Young Lee, Eun Sook Kim, Su Yeon Kim, et al.
Gene (2025), pp. 149381-149381
Closed Access
Neurofibromatosis in the Era of Precision Medicine: Development of MEK Inhibitors and Recent Successes with Selumetinib
Robert Galvin, Adrienne L. Watson, David A. Largaespada, et al.
Current Oncology Reports (2021) Vol. 23, Iss. 4
Open Access | Times Cited: 27
Targeted Therapies for the Neurofibromatoses
Lauren Dengle, Ashley Bui, Laura J. Klesse
Cancers (2021) Vol. 13, Iss. 23, pp. 6032-6032
Open Access | Times Cited: 20
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis
Rebecca Brown
Current Oncology Reports (2023) Vol. 25, Iss. 12, pp. 1409-1417
Closed Access | Times Cited: 8
Epilepsy in neurofibromatosis type 1: Diffuse cerebral dysfunction?
Esra Serdaroğlu, Bahadır Konuşkan, Kader Karlı Oğuz, et al.
Epilepsy & Behavior (2019) Vol. 98, pp. 6-9
Closed Access | Times Cited: 23
Genes causing congenital hydrocephalus: Their chromosomal characteristics of telomere proximity and DNA compositions
Ian McKnight, Christoph Hart, In‐Hyun Park, et al.
Experimental Neurology (2020) Vol. 335, pp. 113523-113523
Open Access | Times Cited: 23
Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism
Eric Legius, Hilde Brems
Child s Nervous System (2020) Vol. 36, Iss. 10, pp. 2285-2295
Closed Access | Times Cited: 22
Multiparametric whole-body MRI of patients with neurofibromatosis type I: spectrum of imaging findings
Uma Thakur, Shyam Ramachandran, Alexander T. Mazal, et al.
Skeletal Radiology (2024)
Closed Access | Times Cited: 2
Understanding the Biological Activities of Vitamin D in Type 1 Neurofibromatosis: New Insights into Disease Pathogenesis and Therapeutic Design
Claudia Riccardi, Lorena Perrone, Filomena Napolitano, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2965-2965
Open Access | Times Cited: 18
Epilepsy in NF1: Epidemiologic, Genetic, and Clinical Features. A Monocentric Retrospective Study in a Cohort of 784 Patients
Ugo Sorrentino, Silvia Bellonzi, Chiara Mozzato, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6336-6336
Open Access | Times Cited: 17
Telomere alterations in neurofibromatosis type 1-associated solid tumors
Fausto J. Rodríguez, Mindy K. Graham, Jacqueline A. Brosnan‐Cashman, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 17
Molecular Determinants of Neurocognitive Deficits in Glioma: Based on 2021 WHO Classification
Kun Zhang, Tianrui Yang, Yu Xia, et al.
Journal of Molecular Neuroscience (2024) Vol. 74, Iss. 1
Open Access | Times Cited: 1
Pediatric-Like Brain Tumors in Adults
Sandra Fernandes Dias, Oliver C. Richards, Martin Elliot, et al.
Advances and technical standards in neurosurgery (2024), pp. 147-183
Closed Access | Times Cited: 1
Role of long non-coding RNAs in neurofibromatosis and Schwannomatosis: pathogenesis and therapeutic potential
Md Sadique Hussain, Somya Sharma, Alka Kumari, et al.
Epigenomics (2024) Vol. 16, Iss. 23-24, pp. 1453-1464
Closed Access | Times Cited: 1
Increased epileptogenicity in a mouse model of neurofibromatosis type 1
Azadeh Sabetghadam, Chenggang Wu, J. Liu, et al.
Experimental Neurology (2020) Vol. 331, pp. 113373-113373
Closed Access | Times Cited: 11
Global microRNA profiling identified miR‐10b‐5p as a regulator of neurofibromatosis 1 (NF1)‐glioma migration
J. Stephen Nix, M. Yuan, Eddie L. Imada, et al.
Neuropathology and Applied Neurobiology (2020) Vol. 47, Iss. 1, pp. 96-107
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top